351 related articles for article (PubMed ID: 38195680)
1. Carrier systems of radiopharmaceuticals and the application in cancer therapy.
Zhang T; Lei H; Chen X; Dou Z; Yu B; Su W; Wang W; Jin X; Katsube T; Wang B; Zhang H; Li Q; Di C
Cell Death Discov; 2024 Jan; 10(1):16. PubMed ID: 38195680
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer.
Alati S; Singh R; Pomper MG; Rowe SP; Banerjee SR
Semin Nucl Med; 2023 Sep; 53(5):663-686. PubMed ID: 37468417
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapy in nuclear medicine--current status and future prospects.
Oyen WJ; Bodei L; Giammarile F; Maecke HR; Tennvall J; Luster M; Brans B
Ann Oncol; 2007 Nov; 18(11):1782-92. PubMed ID: 17434893
[TBL] [Abstract][Full Text] [Related]
4. Radionuclide therapy of cancer with radiolabeled antibodies.
Boerman OC; Koppe MJ; Postema EJ; Corstens FH; Oyen WJ
Anticancer Agents Med Chem; 2007 May; 7(3):335-43. PubMed ID: 17504159
[TBL] [Abstract][Full Text] [Related]
5. Current Status of Radiolabeled Monoclonal Antibodies Targeting PSMA for Imaging and Therapy.
Abusalem M; Martiniova L; Soebianto S; DePalatis L; Ravizzini G
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760506
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic radiopharmaceuticals.
Ercan MT; Caglar M
Curr Pharm Des; 2000 Jul; 6(11):1085-121. PubMed ID: 10903384
[TBL] [Abstract][Full Text] [Related]
7. Biological carrier molecules of radiopharmaceuticals for molecular cancer imaging and targeted cancer therapy.
Aerts A; Impens NR; Gijs M; D'Huyvetter M; Vanmarcke H; Ponsard B; Lahoutte T; Luxen A; Baatout S
Curr Pharm Des; 2014; 20(32):5218-44. PubMed ID: 24606796
[TBL] [Abstract][Full Text] [Related]
8. New Frontiers in Molecular Imaging Using Peptide-Based Radiopharmaceuticals for Prostate Cancer.
Li X; Cai H; Wu X; Li L; Wu H; Tian R
Front Chem; 2020; 8():583309. PubMed ID: 33335885
[TBL] [Abstract][Full Text] [Related]
9. Peptide motifs for insertion of radiolabeled biomolecules into cells and routing to the nucleus for cancer imaging or radiotherapeutic applications.
Costantini DL; Hu M; Reilly RM
Cancer Biother Radiopharm; 2008 Feb; 23(1):3-24. PubMed ID: 18298325
[TBL] [Abstract][Full Text] [Related]
10. Treatment with Radiopharmaceuticals and Radionuclides in Breast Cancer: Current Options.
Altıparmak Güleç B; Yurt F
Eur J Breast Health; 2021 Jul; 17(3):214-219. PubMed ID: 34263148
[TBL] [Abstract][Full Text] [Related]
11. Radiolabeled peptides in diagnosis and therapy.
Weiner RE; Thakur ML
Semin Nucl Med; 2001 Oct; 31(4):296-311. PubMed ID: 11710772
[TBL] [Abstract][Full Text] [Related]
12. Antibody-based Radiopharmaceuticals as Theranostic Agents: An Overview.
Sharma R; Suman SK; Mukherjee A
Curr Med Chem; 2022; 29(38):5979-6005. PubMed ID: 35674298
[TBL] [Abstract][Full Text] [Related]
13. Radiopharmaceuticals for the Diagnosis and Therapy of Neuroendocrine Differentiated Prostate Cancer.
Giovacchini G; Giovannini E; Riondato M; Ciarmiello A
Curr Radiopharm; 2017; 10(1):6-15. PubMed ID: 28034291
[TBL] [Abstract][Full Text] [Related]
14. Radiolabeled Peptides for SPECT and PET Imaging in the Detection of Breast Cancer: Preclinical and Clinical Perspectives.
Fu H; Du B; Chen Z; Li Y
Curr Med Chem; 2020; 27(41):6987-7002. PubMed ID: 32003658
[TBL] [Abstract][Full Text] [Related]
15. Peptide-based radiopharmaceuticals and cytotoxic conjugates: potential tools against cancer.
Okarvi SM
Cancer Treat Rev; 2008 Feb; 34(1):13-26. PubMed ID: 17870245
[TBL] [Abstract][Full Text] [Related]
16. Tumor imaging and therapy using radiolabeled somatostatin analogues.
de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP
Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476
[TBL] [Abstract][Full Text] [Related]
17. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.
Smith-Jones PM; Vallabhajosula S; Navarro V; Bastidas D; Goldsmith SJ; Bander NH
J Nucl Med; 2003 Apr; 44(4):610-7. PubMed ID: 12679407
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic applications of radiolabeled peptides in nuclear endocrinology.
Behr TM; Béhé M; Becker W
Q J Nucl Med; 1999 Sep; 43(3):268-80. PubMed ID: 10568142
[TBL] [Abstract][Full Text] [Related]
19. Application of radiolabeled peptides in tumor imaging and therapy.
Mohtavinejad N; Shafiee Ardestani M; Khalaj A; Pormohammad A; Najafi R; Bitarafan-Rajabi A; Hajiramezanali M; Amanlou M
Life Sci; 2020 Oct; 258():118206. PubMed ID: 32758623
[TBL] [Abstract][Full Text] [Related]
20. MUC1-Targeted Radiopharmaceuticals in Cancer Imaging and Therapy.
Maleki F; Rezazadeh F; Varmira K
Mol Pharm; 2021 May; 18(5):1842-1861. PubMed ID: 33821638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
